Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $84.91 -4.15%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.68), $0.11 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $32.41 million versus the consensus estimate of $49.23 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Hafnia Limited (HAFN) Tops Q2 EPS by 1c
- Benchmark Reiterates Buy Rating on Marvell (MRVL) Following Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
